Walter and Eliza Hall Institute of Medical Research
2 clinical trials · Sponsor
◉ Watch Walter and Eliza Hall Institute of Medical Research
| Record | Firm | Date |
|---|---|---|
| Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer (NCT03691012) | Walter and Eliza Hall Institute of Medical Research | 2017-05-09 |
| Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours (NCT04122430) | Walter and Eliza Hall Institute of Medical Research | 2015-12-01 |
Track Walter and Eliza Hall Institute of Medical Research automatically
Every clearance here is in the API, with alerts when new ones post.